Medication

FILE - In this Jan. 17, 2019, file photo, a sign with the Sackler name is displayed at the Metropolitan Museum of Art in New York. Their name used to be on a wing at the Louvre. But now the Sackler family wealth has become linked to sales of OxyContin, and their company, drug maker Purdue Pharma, is attempting to settle lawsuits over the opioid crisis. (AP Photo/Seth Wenig, File)
September 19, 2019 - 5:24 pm
For a family with its name on a wing of one of the world's most famous museums and a school at a prestigious university, members of the Sackler clan have done a remarkable job of vanishing from public life. The family owns OxyContin maker Purdue Pharma, which filed for bankruptcy this week as part...
Read More
Speaker of the House Nancy Pelosi, D-Calif., arrives for a closed-door meeting with the House Democratic Caucus, Wednesday, Sept. 18, 2019, at the Capitol in Washington. (AP Photo/J. Scott Applewhite)
September 19, 2019 - 4:05 pm
WASHINGTON (AP) — House Speaker Nancy Pelosi, trying to seize the agenda on a leading consumer issue, announced an ambitious prescription drug plan Thursday that would allow Medicare to negotiate prices for seniors and younger people. The proposal would direct Medicare to bargain over as many as...
Read More
September 19, 2019 - 11:20 am
The U.S. government will spend $3 million to find out if marijuana can relieve pain, but none of the money will be used to study the part of the plant that gets people high. Nine research grants announced Thursday are for work on CBD, the trendy ingredient showing up in cosmetics and foods, and...
Read More
FILE - In this Nov. 5, 2018 file photo, a drugstore employee reaches for medicine from shelf in downtown Tehran, Iran. A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes. The results published Wednesday, Sept. 18, 2019, suggest the combo pill can lower blood pressure and bad cholesterol. Experts say the study may draw U.S. interest to a strategy that has been seen as useful only in places with limited access to medical care. (AP Photo/Ebrahim Noroozi, File)
September 18, 2019 - 6:45 pm
A cheap, daily pill that combines four drugs has been tested for the first time in the United States to see if it works as well among low-income Americans as it has in other countries to treat conditions leading to heart attacks and strokes. Experts said the study may draw U.S. interest to a...
Read More
FILE - In this Thursday, Sept. 12, 2019 file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. The allegations surrounding wealthy donors such as the Sackler family have raised questions for the museums they supported, including whether to keep the family's name on prominent galleries. The billionaire family is notorious for its ties to the drug company Purdue Pharma, which developed OxyContin, a painkiller that has been at the center of the opioid crisis. (AP Photo/Frank Franklin II, File)
September 18, 2019 - 1:13 am
NEW YORK (AP) — Ask the CEO and president of the Metropolitan Museum of Art whether he's accepting money from the Sacklers, the billionaire dynasty notorious for its ties to the drug company Purdue Pharma, and the answer is somewhat complicated. For one thing, it depends on which Sackler. "There...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
September 17, 2019 - 4:42 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
September 16, 2019 - 5:11 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
September 16, 2019 - 2:41 pm
Good afternoon! Here's a look at how AP’s news coverage is shaping up today in the Deep South. Questions about today's coverage plans are welcome and should be directed to: The Atlanta AP Bureau at 404-522-8971 or apatlanta@ap.org The Columbia AP Bureau at 803-799-5510 or apcolumbia@ap.org The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 16, 2019 - 2:26 pm
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More
September 16, 2019 - 10:04 am
CARNESVILLE, Ga. (AP) — A Georgia paramedic is accused of stealing morphine, replacing it with another liquid and then re-attaching the cap with super glue. Prosecutors say Michael Shane Hambrick knew the vial he left behind would be intended for critically injured patients who are in need of the...
Read More

Pages